Startup profile · funding coverage

Accolade

Personalized healthcare navigation and benefits platform for employers.

Stage

public

Status

public

Coverage

full

Why Accolade is interesting

Accolade pairs human Health Assistants with cloud software to help employees navigate benefits and care — a16z was a major holder before its 2020 Nasdaq IPO (ACCD).

Key facts

IPO (Jul 2020): $253.6M at ~$1.2B on Nasdaq (ACCD); a16z held ~16.2% pre-IPO (GeekWire)
Exit highlight: a16z portfolio company — public markets exit via IPO
Co-investors: no additional institutional investors disclosed in public sources reviewed 2026-07-24

Investors in our directory

Funds linked from Accolade's profile — open a fund page for stage focus and related deal articles.

Andreessen Horowitz

Venture Capital Tracker